Boehringer Ingelheim Collaborates with Sosei Heptares for Antipsychotic Drugs
By Amit Kaushik
Pharma Deals Review: Vol 2024 Issue 3 (Table of Contents)
Published: 27 Mar-2024
DOI: 10.3833/pdr.v2024.i3.2866 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In an attempt to diversify its pipeline, Boehringer Ingelheim has signed a strategic collaboration and licensing agreement, worth up to €755 M (US$825...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS